|
End-of-day quote
Korea S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 970.00 KRW | +1.78% |
|
-3.00% | -45.57% |
| 08-03 | Amicogen, Inc. cancelled the transaction announced on June 22, 2026 | CI |
| 06-21 | Amicogen, Inc. announced that it expects to receive KRW 9.9999989 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMICOGEN, INC. | Bio Therapeutic Drugs | +1.78% | -3.00% | -45.57% | -71.68% | -94.83% | 49.59M |  | | |
- Stock Market
- Stocks
- A092040 Stock
- Charts Amicogen, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
